Intel stock extends gains after report of possible U.S. government stake
QINGDAO, China - Akso Health Group (NASDAQ: AHG), a medical technology company with a market capitalization of $373 million, announced the integration of DeepSeek’s artificial intelligence technology into its services. According to InvestingPro data, the company maintains a strong financial position with more cash than debt on its balance sheet, though its stock has experienced a 4.41% decline year-to-date. This collaboration is aimed at improving AI-powered medical consultation, optimizing healthcare resource allocation, and providing more precise medical services.
The integration involves leveraging DeepSeek’s multimodal large-scale models, deep learning frameworks, and big data processing capabilities to enhance AHG’s AI-powered diagnosis system. This strategic move comes as the company faces challenges with its gross profit margins, currently at 5.06%, according to InvestingPro analysis, which offers 8 additional key insights about the company’s performance. The system will now be able to integrate patient text descriptions, medical imaging, and laboratory test results, using natural language processing (NLP) and deep learning to provide more accurate diagnoses and personalized treatment recommendations.
In addition to diagnostic improvements, AHG plans to develop an AI-powered medical assistant to support doctors in retrieving patient records, analyzing similar cases, and recommending treatment plans. This is expected to significantly improve diagnostic efficiency. The company also emphasizes the incorporation of human-centric AI interactions to ensure a more natural and empathetic user experience, aiming to reduce patient anxiety and optimize the consultation process.
CEO of AHG, Ms. Yilin (Linda) Wang, remarked on the significance of utilizing DeepSeek’s technology, stating it is a major milestone in AI-powered healthcare. With current revenue at $2.41 million and a stock price of $1.30, AHG’s future plans include further exploration of AI applications in research and development, health management, and telemedicine, with the goal of driving the healthcare industry toward a smarter and more efficient future. For deeper insights into AHG’s financial health and growth potential, investors can access comprehensive analysis through InvestingPro.
Akso Health Group, which specializes in the sales of medical devices in China and the United States, has recently expanded its services to include online medical consultations through its acquisition of equity interests in Tianjin Deyihui Internet Hospital Co., Ltd and Tianjin Deyihui Clinic Co., Ltd in March 2024.
This announcement contains forward-looking statements regarding the company’s future plans and potential benefits of the technology integration. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995 and involve certain risks and uncertainties.
The information provided in this announcement is based on a press release statement from Akso Health Group.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.